To hear about similar clinical trials, please enter your email below

Trial Title: Quality Of Life On Elderly Patients With Low Grade Non-Hodgkin Lymphoma

NCT ID: NCT05524298

Condition: Low Grade Non-Hodgkin's Lymphoma, Adult

Conditions: Official terms:
Lymphoma
Lymphoma, Non-Hodgkin

Study type: Observational

Overall status: Recruiting

Study design:

Time perspective: Prospective

Summary: Aims of this study are to describe the variation of QoL (Quality of Life) during the clinical management of low-grade lymphoma in elderly subjects and to identify the most important factors at diagnosis and during treatment with an impact on QoL (Quality of Life).

Detailed description: This is a prospective, multicenter, non-interventional study aiming at investigating on the changes in QoL (Quality of Life) during the clinical management of low-grade lymphoma in elderly subjects and to possibly identify the most important factors at diagnosis and during treatment with an impact on QoL (Quality of Life). The study plans to enroll 150 patients with a local histologically confirmed diagnosis of indolent non-Hodgkin lymphoma fulfilling all the inclusion/exclusion criteria who provide written informed consent will be included in the study. Any type of treatment is allowed by the study (immunotherapy, immunochemotherapy at full or reduced dose, radiotherapy). All patients must undergo Comprehensive Geriatric Assessment (CGA) before starting any protocol treatment. Baseline, post-treatment and follow-up instrumental assessments and response evaluation is done as part of the routine clinical management for patients with indolent NHL (Non Hodgkin Lymphoma) . Response evaluation and all other assessments planned for the EOT (end of treatment) should be planned also in case of early withdrawal, according to clinical practice. HRQoL (Health-related Quality of Life) evaluation will be done at time of informed consent form signature prior to treatment start, at the end of the treatment (ranging from 1 month to 6 months according to the duration of the treatment) and after 1 year from the start of the therapy. QoL (quality of life) assessment includes all scales of the EORTC-QLQ-C30 (European Organisation for Research and Treatment of Cancer Quality of life Questionnaire-Core 30) and the FACT-Lym-LymS (Functional Assessment of Cancer Therapy - Lymphoma - lymphoma-specific symptoms questionnaire).

Criteria for eligibility:

Study pop:
Elderly Patients With Low Grade Non-Hodgkin Lymphoma Treated With Immunotherapy Or Immunochemotherapy And/Or Radiotherapy.

Sampling method: Non-Probability Sample
Criteria:
Inclusion Criteria: - Local histological diagnosis of indolent B cell non-Hodgkin lymphoma: follicular lymphoma, marginal zone lymphoma (nodal, MALT (Mucosa-Associated Lymphoid Tissue), splenic), lymphoplasmacytic lymphoma/ Waldenström macroglobulinemia) - Age ≥ 70 years - Patient candidates to receive treatment for lymphoma - Patient previously untreated for lymphoma - Evaluation of Comprehensive Geriatric Assessment at baseline - Ability to provide informed consent: subject understands and voluntarily signs an informed consent form approved by an IEC (Independent Ethics Committee), prior to registration into the study Note: Patient treated in the context of a clinical trial is admitted Exclusion Criteria: - none

Gender: All

Minimum age: 70 Years

Maximum age: N/A

Healthy volunteers: No

Locations:

Facility:
Name: S.C. Ematologia - A.O. SS. Antonio e Biagio e Cesare Arrigo

Address:
City: Alessandria
Zip: 15121
Country: Italy

Status: Recruiting

Contact:
Last name: Manuela Zanni, MD
Email: manuela.zanni@ospedale.al.it

Investigator:
Last name: Manuela Zanni
Email: Principal Investigator

Facility:
Name: Clinica di Ematologia - A.O.U. Ospedali Riuniti

Address:
City: Ancona
Zip: 60126
Country: Italy

Status: Recruiting

Contact:
Last name: Guido Gini, MD
Email: guido.gini@ospedaliriuniti.marche.it

Investigator:
Last name: Gini Guido
Email: Principal Investigator

Facility:
Name: Divisione di Oncologia e dei Tumori immuno-correlati - IRCCS Centro di Riferimento Oncologico di Aviano

Address:
City: Aviano
Zip: 33081
Country: Italy

Status: Recruiting

Contact:
Last name: Michele Spina, MD
Email: mspina@cro.it

Investigator:
Last name: Michele Spina
Email: Principal Investigator

Facility:
Name: U.O.C. Ematologia - IRCCS Istituto Tumori Giovanni Paolo II

Address:
City: Bari
Zip: 70124
Country: Italy

Status: Recruiting

Contact:
Last name: Carla Minoia, MD
Email: carlaminoia@libero.it

Investigator:
Last name: Carla Minoia
Email: Principal Investigator

Facility:
Name: Ematologia - ASST Spedali Civili di Brescia

Address:
City: Brescia
Zip: 25123
Country: Italy

Status: Recruiting

Contact:
Last name: Alessandra Tucci, MD
Email: alessandra.tucci@asst-spedalicivili.it

Investigator:
Last name: Alessandra Tucci
Email: Principal Investigator

Facility:
Name: Ematologia - Ospedale di Castelfranco Veneto

Address:
City: Castelfranco Veneto
Zip: 31033
Country: Italy

Status: Recruiting

Contact:
Last name: Roberto Sartori, MD
Email: roberto.sartori@iov.veneto.it

Investigator:
Last name: Roberto Sartori
Email: Principal Investigator

Facility:
Name: U.O.C. di Ematologia - Azienda Ospedaliera Universitaria Policlinico - Rodolico S. Marco

Address:
City: Catania
Zip: 95123
Country: Italy

Status: Recruiting

Contact:
Last name: Annalisa Chiarenza, MD

Investigator:
Last name: Annalisa Chiarenza
Email: Principal Investigator

Facility:
Name: Unità funzionale di Ematologia - Azienda Ospedaliera Universitaria Careggi

Address:
City: Firenze
Zip: 50141
Country: Italy

Status: Not yet recruiting

Contact:
Last name: Benedetta Puccini, MD
Email: puccinib@aou-careggi.toscana.it

Investigator:
Last name: Benedetta Puccini
Email: Principal Investigator

Facility:
Name: S.C. Ematologia - Azienda Ospedali Riuniti Papardo-Piemonte

Address:
City: Messina
Zip: 98158
Country: Italy

Status: Not yet recruiting

Contact:
Last name: Donato Mannina, MD
Email: donamanni@gmail.com

Investigator:
Last name: Donato Mannina
Email: Principal Investigator

Facility:
Name: Unitа Linfomi - Dipartimento Oncoematologia, Istituto Scientifico San Raffaele

Address:
City: Milano
Zip: 20132
Country: Italy

Status: Recruiting

Contact:
Last name: Andrés Ferreri, MD
Email: andres.ferreri@hsr.it

Investigator:
Last name: Andrés Ferreri
Email: Principal Investigator

Facility:
Name: S.C. Ematologia - ASST Grande Ospedale Metropolitano Niguarda

Address:
City: Milano
Zip: 20162
Country: Italy

Status: Recruiting

Contact:
Last name: Cristina Muzi, MD
Email: cristina.muzi@ospedaleniguarda.it

Investigator:
Last name: Cristina Muzi
Email: Principal Investigator

Facility:
Name: Ematologia - A.O.U. Policlinico Giaccone

Address:
City: Palermo
Zip: 90127
Country: Italy

Status: Recruiting

Contact:
Last name: Salvatrice Mancuso, MD
Email: salvatrice.mancuso@unipa.it

Investigator:
Last name: Salvatrice Mancuso
Email: Principal Investigator

Facility:
Name: Divisione di Ematologia - A.O. Ospedali Riuniti Villa Sofia-Cervello

Address:
City: Palermo
Zip: 90146
Country: Italy

Status: Not yet recruiting

Contact:
Last name: Caterina Patti, MD
Email: k.patti@villasofia.it

Investigator:
Last name: Caterina Patti
Email: Principal Investigator

Facility:
Name: U.O. Ematologia - Ospedale Guglielmo da Saliceto

Address:
City: Piacenza
Zip: 29121
Country: Italy

Status: Recruiting

Contact:
Last name: Annalisa Arcari, MD
Email: a.arcari@ausl.pc.it

Investigator:
Last name: Annalisa Arcari
Email: Principal Investigator

Facility:
Name: Ematologia - Azienda Unitа Sanitaria Locale-IRCCS - Arcispedale Santa Maria Nuova

Address:
City: Reggio Emilia
Zip: 42123
Country: Italy

Status: Recruiting

Contact:
Last name: Maria Elena Nizzoli, MD
Email: mariaelena.nizzoli@ausl.re.it

Investigator:
Last name: Maria Elena Nizzoli
Email: Principal Investigator

Facility:
Name: U.O. di Ematologia - Ospedale degli Infermi di Rimini

Address:
City: Rimini
Zip: 47923
Country: Italy

Status: Recruiting

Contact:
Last name: Melania Celli, MD
Email: melania.celli@auslromagna.it

Investigator:
Last name: Melania Celli
Email: Principal Investigator

Facility:
Name: Ematologia,Trapianto cellule staminali, Medicina Trasfusionale e Terapia cellulare -Policlinico Universitario Campus Bio-Medico

Address:
City: Roma
Zip: 00128
Country: Italy

Status: Recruiting

Contact:
Last name: Ombretta Annibali, MD
Email: o.annibali@policlinicocampus.it

Investigator:
Last name: Ombretta Annibali
Email: Principal Investigator

Facility:
Name: U.O.C. Ematologia - A.O.U. Senese

Address:
City: Siena
Zip: 53100
Country: Italy

Status: Recruiting

Contact:
Last name: Alberto Fabbri, MD
Email: fabbri7@unisi.it

Investigator:
Last name: Alberto Fabbri
Email: Principal Investigator

Facility:
Name: U.O.C. Ematologia - Ospedale di Circolo

Address:
City: Varese
Zip: 21100
Country: Italy

Status: Not yet recruiting

Contact:
Last name: Michele Merli, MD
Email: michele.merli@asst-settelaghi.it

Investigator:
Last name: Michele Merli
Email: Principal Investigator

Start date: December 7, 2022

Completion date: February 2025

Lead sponsor:
Agency: Fondazione Italiana Linfomi - ETS
Agency class: Other

Source: Fondazione Italiana Linfomi - ETS

Record processing date: ClinicalTrials.gov processed this data on November 12, 2024

Source: ClinicalTrials.gov page: https://clinicaltrials.gov/ct2/show/NCT05524298

Login to your account

Did you forget your password?